Kano Y - Search Results

1

A phase II study of irinotecan and infusional cisplatin with recombinant human granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer.

Mori K, Machida S, Yoshida T, Yoshida M, Kano Y, Tominaga K. Mori K, et al. Among authors: kano y. Cancer Chemother Pharmacol. 1999;43(6):467-70. doi: 10.1007/s002800050925. Cancer Chemother Pharmacol. 1999. PMID: 10321506 Clinical Trial.

2

A phase II study of docetaxel and infusional cisplatin in advanced non-small-cell lung cancer.

Mori K, Kamiyama Y, Kondo T, Kano Y, Kodama T. Mori K, et al. Among authors: kano y. Chemotherapy. 2005 May;51(2-3):120-5. doi: 10.1159/000085619. Epub 2005 May 9. Chemotherapy. 2005. PMID: 15886471 Clinical Trial.

3

Pilot phase II study of weekly chemotherapy with paclitaxel and carboplatin for refractory or relapsed small-cell lung cancer.

Mori K, Kamiyama Y, Kondo T, Kano Y, Kodama T. Mori K, et al. Among authors: kano y. Cancer Chemother Pharmacol. 2006 Jul;58(1):86-90. doi: 10.1007/s00280-005-0114-4. Epub 2006 Jan 31. Cancer Chemother Pharmacol. 2006. PMID: 16447041 Clinical Trial.

4

Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy.

Mori K, Kamiyama Y, Kondo T, Kano Y, Kodama T. Mori K, et al. Among authors: kano y. Cancer Chemother Pharmacol. 2007 Jul;60(2):189-95. doi: 10.1007/s00280-006-0360-0. Epub 2006 Nov 10. Cancer Chemother Pharmacol. 2007. PMID: 17096163 Clinical Trial.

5

A phase II trial of weekly chemotherapy with paclitaxel plus gemcitabine as a first-line treatment in advanced non-small-cell lung cancer.

Mori K, Kobayashi H, Kamiyama Y, Kano Y, Kodama T. Mori K, et al. Among authors: kano y. Cancer Chemother Pharmacol. 2009 Jun;64(1):73-8. doi: 10.1007/s00280-008-0846-z. Epub 2008 Oct 22. Cancer Chemother Pharmacol. 2009. PMID: 18941748 Clinical Trial.

6

Preventive effect of Kampo medicine (Hangeshashin-to) against irinotecan-induced diarrhea in advanced non-small-cell lung cancer.

Mori K, Kondo T, Kamiyama Y, Kano Y, Tominaga K. Mori K, et al. Among authors: kano y. Cancer Chemother Pharmacol. 2003 May;51(5):403-6. doi: 10.1007/s00280-003-0585-0. Epub 2003 Apr 9. Cancer Chemother Pharmacol. 2003. PMID: 12687289 Clinical Trial.

7

Phase II study of the combination of vinorelbine and cisplatin in advanced non-small-cell lung cancer.

Mori K, Kamiyama Y, Kondo T, Kano Y, Tominaga K. Mori K, et al. Among authors: kano y. Cancer Chemother Pharmacol. 2004 Feb;53(2):129-32. doi: 10.1007/s00280-003-0707-8. Epub 2003 Nov 7. Cancer Chemother Pharmacol. 2004. PMID: 14605861 Clinical Trial.

8

In vitro schedule-dependent interaction between paclitaxel and SN-38 (the active metabolite of irinotecan) in human carcinoma cell lines.

Kano Y, Akutsu M, Tsunoda S, Mori K, Suzuki K, Adachi KI. Kano Y, et al. Cancer Chemother Pharmacol. 1998;42(2):91-8. doi: 10.1007/s002800050790. Cancer Chemother Pharmacol. 1998. PMID: 9654107

9

Schedule-dependent interactions between paclitaxel and etoposide in human carcinoma cell lines in vitro.

Kano Y, Akutsu M, Suzuki K, Mori K, Yazawa Y, Tsunoda S. Kano Y, et al. Cancer Chemother Pharmacol. 1999;44(5):381-8. doi: 10.1007/s002800050993. Cancer Chemother Pharmacol. 1999. PMID: 10501911

10

Schedule-dependent synergism and antagonism between pemetrexed and paclitaxel in human carcinoma cell lines in vitro.

Kano Y, Akutsu M, Tsunoda S, Izumi T, Mori K, Fujii H, Yazawa Y, Mano H, Furukawa Y. Kano Y, et al. Cancer Chemother Pharmacol. 2004 Dec;54(6):505-13. doi: 10.1007/s00280-004-0839-5. Epub 2004 Aug 31. Cancer Chemother Pharmacol. 2004. PMID: 15340759

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,203 results

Search Page

Filters